Genmab A/S(DE:GE9)
€478.10-1.20 (-0.25%)
DE:GE9
Genmab A/S Revenue
€478.10
At close:-1.20 (-0.25%)
Genmab A/S (GE9) Revenue
15 Followers
Genmab A/S Revenue
Genmab A/S had a revenue of 1.19B in the quarter ending Sep 30, 2026, with 2.77%. This bring the company's revenue in the last twelve months to 4.30B, Decreased 55.38%. In the fiscal year ending Dec 31, 2025, Genmab A/S had annual revenue of 3.86B with -82.07% growth.
- Revenue (ttm)
- 4.30B
- Revenue Growth
- 14.42%
- P/S Ratio
- 7.42
- Revenue/Employee
- EUR 1,237,512
- Employees
- 3,119
- Market Cap
- EUR 28.63B
Revenue Chart
Genmab A/S Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.86B | -17.67B | -82.07% |
| Dec 31, 2024 | 21.53B | 5.05B | 30.67% |
| Dec 31, 2023 | 16.47B | 1.97B | 13.57% |
| Dec 31, 2022 | 14.51B | 6.02B | 71.01% |
| Dec 31, 2021 | 8.48B | -1.63B | -16.11% |
| Dec 31, 2020 | 10.11B | 4.75B | 88.43% |
| Dec 31, 2019 | 5.37B | 2.34B | 77.38% |
| Dec 31, 2018 | 3.03B | 659.70M | 27.89% |
| Dec 31, 2017 | 2.37B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.